Yazarlar
Charles J Ferro, Patrick B Mark, Mehmet Kanbay, Pantelis Sarafidis, Gunnar H Heine, Patrick Rossignol, Ziad A Massy, Francesca Mallamaci, Jose M Valdivielso, Jolanta Malyszko, Marianne C Verhaar, Robert Ekart, Raymond Vanholder, Gerard London, Alberto Ortiz, Carmine Zoccali
Yayın tarihi
2018/12
Kaynak
Nature Reviews Nephrology
Cilt
14
Sayı
12
Sayfalar
727-749
Yayıncı
Nature Publishing Group UK
Açıklama
An increased risk of cardiovascular disease, independent of conventional risk factors, is present even at minor levels of renal impairment and is highest in patients with end-stage renal disease (ESRD) requiring dialysis. Renal dysfunction changes the level, composition and quality of blood lipids in favour of a more atherogenic profile. Patients with advanced chronic kidney disease (CKD) or ESRD have a characteristic lipid pattern of hypertriglyceridaemia and low HDL cholesterol levels but normal LDL cholesterol levels. In the general population, a clear relationship exists between LDL cholesterol and major atherosclerotic events. However, in patients with ESRD, LDL cholesterol shows a negative association with these outcomes at below average LDL cholesterol levels and a flat or weakly positive association with mortality at higher LDL cholesterol levels. Overall, the available data suggest that lowering of LDL …
Toplam alıntı sayısı
Google Akademik makaleleri
CJ Ferro, PB Mark, M Kanbay, P Sarafidis, GH Heine… - Nature Reviews Nephrology, 2018